Scope
Description
MDC's current imaging capabilities are limited to PET and CT, which restricts us to PET based tracers. While PET imaging is a powerful tool, it cannot accommodate a growing range of radioisotopes that are increasingly relevant in theranostic applications.
These include lead 203, lead 212, lutetium 177, and actinium 225, which are essential for both diagnostic and therapeutic purposes. This limitation has become more pronounced as clinical and research interest in SPECT and CT imaging continues to grow.
SPECT imaging enables biodistribution studies for isotopes that PET cannot support. This opens up new possibilities for molecular imaging and expands our ability to respond to evolving scientific and clinical needs. We have a clear opportunity to address this gap by introducing SPECT and CT capability through the phased procurement of the SPECT Cube module, followed by an upgrade to the advanced SPECT Cube 2.0 platform. This will allow MDC to meet rising diagnostic demand, align with industry standards, and maintain clinical competitiveness.
Contract 1
Supplier
Contract value
- £350,000 excluding VAT
- £420,000 including VAT
Above the relevant threshold
Earliest date the contract will be signed
2 October 2025
Contract dates (estimated)
- 2 October 2025 to 2 January 2027
- 1 year, 3 months, 1 day
Main procurement category
Goods
CPV classifications
- 38000000 - Laboratory, optical and precision equipments (excl. glasses)
Contract locations
- UKD - North West (England)
Other information
Conflicts assessment prepared/revised
Yes
Procedure
Procedure type
Direct award
Direct award justification
Single supplier - technical reasons
The system supports high-energy collimators and emerging radionuclides such as 212-Pb and 203-Pb, which are critical for MDC's research pipeline and are compatible with existing MDC equipment which enables an integrated system allowing simultaneous imaging of SPECT PET and CT imaging in one work flow.
Supplier
SOUTHERN SCIENTIFIC LIMITED
- Companies House: 01800317
Scientific House Henfield Business Park
Henfield
BN5 9SL
United Kingdom
Region: UKJ28 - West Sussex (North East)
Small or medium-sized enterprise (SME): Yes
Voluntary, community or social enterprise (VCSE): No
Contract 1
Contracting authority
MEDICINES DISCOVERY CATAPULT LIMITED
- Companies House: 09928547
- Public Procurement Organisation Number: PJPQ-6911-DQYY
Block 35g, Mereside Alderley Park
Macclesfield
SK10 4ZF
United Kingdom
Region: UKD62 - Cheshire East
Organisation type: Public authority - sub-central government